Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 20-Jun-2013
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 4 of 4)
Release
Date [down]		 Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
19-Jun-13ValuEngine, Inc.N/AValuEngine Industry Report for Medical-drugs18$207  View Abstract
15-Jun-13S&P Capital IQ Quantitative ReportN/APoniard Pharmaceuticals5$57.50  View Abstract
14-Jun-13Reuters Investment ProfileN/APoniard Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138  View Abstract
24-May-13GlobalDataGlobalDataPoniard Pharmaceuticals, Inc. (PARD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile31$250  View Abstract
Independent Reports (Showing 1 to 4 of 4)
Release
Date [down]		 Contributor Author Title Pages Price More Info
19-Jun-13ValuEngine, Inc.N/AValuEngine Industry Report for Medical-drugs18$207View Abstract
15-Jun-13S&P Capital IQ Quantitative ReportN/APoniard Pharmaceuticals5$57.50View Abstract
14-Jun-13Reuters Investment ProfileN/APoniard Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$138View Abstract
24-May-13GlobalDataGlobalDataPoniard Pharmaceuticals, Inc. (PARD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile31$250View Abstract

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.